fbpx Australia: Creso Pharma to Launch Cannabis-Based Nutraceutical Product in Swiss Market | Marijuana Business News | Cannabis Industry & Legalization | 420 Intel

Australia: Creso Pharma to Launch Cannabis-Based Nutraceutical Product in Swiss Market

Creso Pharma Ltd (ASX:CPH) has partnered with Swiss pharmaceutical firm, Streuli Pharma, to commercialise its first human nutraceutical product, INNutri Soft Gums in the Swiss market.

Creso’s strategy is to develop and commercialise pharmaceutical-grade cannabis and hemp-based products for the nutraceutical (food supplement) market.

INNutri Soft Gums use an innovative and proprietary delivery technology allowing for an optimum delivery of cannabis and hemp derived therapeutic products.

The cannabis is delivered through buccal (mouth) absorption and the soft gums have several advantages over existing health supplement products.

Importantly, Creso will have access to the distribution network of Streuli Pharma, which currently manufacture over 150 million tablets and capsules per annum.

Creso started trading on the ASX last week, following a successful initial public offering (IPO) that raised $5 million.

The IPO was significantly oversubscribed and puts the company in a strong financial position to further develop its pharmaceutical-grade cannabis and hemp-based...

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.